Novo Nordisk Foundation Center for Basic Metabolic Research

  1. Published

    Birthweight, Childhood Body Mass Index, Height and Growth, and Risk of Polycystic Ovary Syndrome

    Aarestrup, J., Pedersen, D. C., Thomas, P. E., Glintborg, D., Holm, Jens-Christian, Bjerregaard, L. G. & Baker, J. L., 2021, In: Obesity Facts. 14, 3, p. 283-290 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Childhood body mass index and height and risk of histologic subtypes of endometrial cancer

    Aarestrup, J., Gamborg, Michael Orland, Ulrich, L. G., Sørensen, Thorkild I.A. & Baker, J. L., 2016, In: International Journal of Obesity. 40, p. 1096-1102 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Childhood height increases the risk of prostate cancer mortality

    Aarestrup, J., Gamborg, Michael Orland, Cook, M. B. & Baker, J. L., Jul 2015, In: European Journal of Cancer. 51, 10, p. 1340-1345 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Childhood body mass index and the risk of prostate cancer in adult men

    Aarestrup, J., Gamborg, Michael Orland, Cook, M. B., Sørensen, Thorkild I.A. & Baker, J. L., 2014, In: B J C. 111, p. 207-212 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Tracking of body mass index from 7 to 69 years of age

    Aarestrup, J., Bjerregaard, L. G., Gamborg, Michael Orland, Ängquist, Lars, Tjønneland, Anne, Overvad, K., Linneberg, Allan René, Osler, Merete, Mortensen, Erik Lykke, Gyntelberg, F., Lund, Rikke, Sørensen, Thorkild I.A. & Baker, J. L., Sep 2016, In: International Journal of Obesity. 40, 9, p. 1376-1383 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    In vivo characterization of the ultrapotent monoacylglycerol lipase inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)

    Aaltonen, N., Kedzierska, E., Orzelska-Górka, J., Lehtonen, M., Navia-Paldanius, D., Jakupovic, Hermina, Savinainen, J. R., Nevalainen, T., Laitinen, J. T., Parkkari, T. & Gynther, M., Oct 2016, In: Journal of Pharmacology and Experimental Therapeutics. 359, 1, p. 62-72 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Understanding risk and causal mechanisms for developing obesity in infants and young children: A National Institutes of Health workshop

    Aagaard, K. M., Barkin, S. L., Burant, C. F., Carnell, S., Demerath, E., Donovan, S. M., Eneli, I., Francis, L. A., Gilbert-Diamond, D., Hivert, M. F., LeBourgeois, M. K., Loos, R. J. F., Lumeng, J. C., Miller, A. L., Okely, A. D., Osganian, S. K., Ramirez, A. G., Trasande, L., Van Horn, L. V., Wake, M. & 2 others, Wright, R. J. & Yanovski, S. Z., 2024, In: Obesity Reviews. 25, 4, 21 p., e13690.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors

    Aaboe, K., Akram, S., Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., Jan 2015, In: Diabetes, Obesity and Metabolism. 17, 1, p. 74-81 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway

    't Hart, L. M., Fritsche, A., Nijpels, G., van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N. A., van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M. C., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., Machicao, F. & 14 others, Willemsen, G., Heine, R. J., Kramer, M., Holst, Jens Juul, de Koning, E. J. P., Häring, H., Pedersen, Oluf Borbye, Groop, L., de Geus, E. J. C., Slagboom, P. E., Boomsma, D. I., Eekhoff, E. M. W., Pearson, E. R. & Diamant, M., 14 May 2013, In: Diabetes. 62, 9, p. 3275-3281 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    In vivo efficacy of HD0471953: A novel GPR119 agonist for the treatment of type 2 diabetes mellitus

    'T Hart, L. M., Fritsche, A., Nijpels, G., Van Leeuwen, N., Donnelly, L. A., Dekker, J. M., Alssema, M., Fadista, J., Carlotti, F., Gjesing, A. P., Palmer, C. N., Van Haeften, T. W., Herzberg-Schäfer, S. A., Simonis-Bik, A. M., Houwing-Duistermaat, J. J., Helmer, Q., Deelen, J., Guigas, B., Hansen, T., MacHicao, F. & 14 others, Willemsen, G., Heine, R. J., Kramer, M. H., Holst, Jens Juul, De Koning, E. J., Häring, H. U., Pedersen, O., Groop, L., De Geus, E. J., Slagboom, P. E., Boomsma, D. I., Eekhoff, E. M., Pearson, E. R. & Diamant, M., 1 Feb 2015, In: Diabetes Technology & Therapeutics. 17, p. S131-S133

    Research output: Contribution to journalComment/debateResearchpeer-review